Cancer survivors in older age Cancer
Conditions
Interventions
Current interventions as of 28/08/2025:
Participants will be randomized into one of the two arms:
1. IMPULS-A program: participants undergo a screening every 6 months to assess their needs and will
Sponsors
University Hospital Heidelberg
Eligibility
Sex/Gender
All
Age
70 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for patients: 1. Expected life expectancy >3 years as assessed by the treating oncologist 2. Increased support needs 3. Ability to give consent 4. Written informed consent Inclusion criteria for relatives: 1. A person named by the patient as a relative who knows about the cancer 2. Minimum age =18 years 3. Ability to give consent 4. Written informed consent Inclusion criteria for practitioners: 1. Belonging to the professional group of doctors, psychologists, physiotherapists, and sports scientists 2. Actively involved in patient care 3. Ability to give consent 4. Written consent
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients: 1. Patients who can no longer care for themselves 2. Insufficient knowledge of written and spoken German 3. Factors that foreseeably severely restrict adherence to treatment (e.g. dementia and/or severe cognitive impairment, significant hearing and/or visual impairment) Exclusion criteria for relatives: Insufficient knowledge of written and spoken German
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health literacy measured using the Health Literacy Questionnaire (HLQ) subscale 2: “Having sufficient information to manage my health” at 18 months after randomization (T2) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Digital health literacy measured using the Health Literacy Survey 2019–2021 (HLS19-DIGI) at 18 months after randomization (T2) 2. Quality of life measured using an abridged version of QLQ-SUR73 at 18 months after randomization (T2) 3. Psychosocial resources measured using the PR-26 at 18 months after randomization (T2) 4. Satisfaction with the medical treatment (measured using the PACIC-S11) at 18 months after randomization (T2) 5. Effects on preventive health measures and the use of care (measured using an abridged version of FIMA) at 9 months after randomisation (T1) and 18 months after randomization (T2) 6. Acceptability, appropriateness and feasibility of the survivorship care model (measured respectively with the Acceptability of intervention measure (AIM), the Intervention appropriateness measure (IAM) and the Feasibility of intervention measure (FIM)) at 18 months after randomization (T2) by participants in the intervention group and their relatives. Practitioners will complete the assessment at the times of “first patient in” and “last patient out” 7. Support needs of relatives in the long-term survival phase (measured with SCNS P&C) at 18 months after randomization (T2) | — |
Countries
Germany
Contacts
Public ContactTill Johannes Bugaj
Outcome results
None listed